Somatic c.34G>T KRAS mutation: A new prescreening test for MUTYH-associated polyposis?

Cancer Genetics

Volumn 208, Issue 7-8, 2015, Pages 390-395

  Aimé, Adeline ^a   Coulet, Florence ^a   Lefevre, Jeremie H ^a   Colas, Chrystelle ^a   Cervera, Pascale ^a   Flejou, Jean François ^a   Lascols, Olivier ^a   Soubrier, Florent ^a   Parc, Yann ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Adenomatous polyposis; Colorectal cancer; KRAS; MUTYH; MUTYH associated polyposis

Indexed keywords

DNA GLYCOSYLASE MUTY; DNA GLYCOSYLTRANSFERASE; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

ADENOCARCINOMA; ADENOMA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; COLORECTAL CANCER; CONTROLLED STUDY; DNA SEQUENCE; EXON; FAMILIAL COLON POLYPOSIS; GENETIC SCREENING; GERMLINE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTYH ASSOCIATED POLYPOSIS; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE K RAS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOMATIC MUTATION; ADENOMATOUS POLYPOSIS COLI; ADULT; COLORECTAL NEOPLASMS; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; POINT MUTATION;

ADENOMATOUS POLYPOSIS COLI; ADULT; BASE SEQUENCE; COLORECTAL NEOPLASMS; DNA GLYCOSYLASES; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; POINT MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 84939469403     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2015.04.005     Document Type: Article

References (32)

1. Al-Tassan N., Chmiel N.H., Maynard J., et al. Inherited variants of MYH associated with somatic G: C-->T: A mutations in colorectal tumors. Nat Genet 2002, 30:227-232.
2. Cleary S.P., Cotterchio M., Jenkins M.A., et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 2009, 136:1251-1260.
3. Institut National du Cancer (INCa) La polypose associée aux mutations bi-alléliques du gène 2011, MUTYH, Boulogne-Billancourt, France.
4. Vogt S., Jones N., Christian D., et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 2009, 137:1976-1985. e1-e10.
5. Wang L., Baudhuin L.M., Boardman L.A., et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 2004, 127:9-16.
6. Croitoru M.E., Cleary S.P., Di Nicola N., et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 2004, 96:1631-1634.
7. Riegert-Johnson D.L., Johnson R.A., Rabe K.G., et al. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing. Genet Test 2007, 11:361-365.
8. Farrington S.M., Tenesa A., Barnetson R., et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 2005, 77:112-119.
9. Lubbe S.J., Di Bernardo M.C., Chandler I.P., et al. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 2009, 27:3975-3980.
10. van Puijenbroek M., Nielsen M., Tops C.M., et al. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. Clin Cancer Res 2008, 14:139-142.
11. Balaguer F., Castellvi-Bel S., Castells A., et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol 2007, 5:379-387.
12. Baglioni S., Melean G., Gensini F., et al. A kindred with MYH-associated polyposis and pilomatricomas. Am J Med Genet A 2005, 134A:212-214.
13. O'Shea A.M., Cleary S.P., Croitoru M.A., et al. Pathological features of colorectal carcinomas in MYH-associated polyposis. Histopathology 2008, 53:184-194.
14. Sampson J.R., Dolwani S., Jones S., et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003, 362:39-41.
15. de Ferro S.M., Suspiro A., Fidalgo P., et al. Aggressive phenotype of MYH-associated polyposis with jejunal cancer and intra-abdominal desmoid tumor: report of a case. Dis Colon Rectum 2009, 52:742-745.
16. Lefevre J.H., Colas C., Coulet F., et al. MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions. Fam Cancer 2010, 9:589-594.
17. Colebatch A., Hitchins M., Williams R., et al. The role of MYH and microsatellite instability in the development of sporadic colorectal cancer. Br J Cancer 2006, 95:1239-1243.
18. Morak M., Heidenreich B., Keller G., et al. Biallelic MUTYH mutations can mimic Lynch syndrome. Eur J Hum Genet 2014, 22:1334-1337.
19. Boparai K.S., Dekker E., Van Eeden S., et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 2008, 135:2014-2018.
20. Castells A. MYH-associated polyposis: adenomas and hyperplastic polyps, partners in crime?. Gastroenterology 2008, 135:1857-1859.
21. Guarinos C., Juarez M., Egoavil C., et al. Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps. Clin Cancer Res 2014, 20:1158-1168.
22. Andreyev H.J., Norman A.R., Cunningham D., et al. Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer 2001, 85:692-696.
23. Lipton L., Halford S.E., Johnson V., et al. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 2003, 63:7595-7599.
24. Jones S., Lambert S., Williams G.T., et al. Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas. Br J Cancer 2004, 90:1591-1593.
25. Lefevre J.H., Rodrigue C.M., Mourra N., et al. Implication of MYH in colorectal polyposis. Ann Surg 2006, 244:874-879. discussion 879-880.
26. Venesio T., Balsamo A., Errichiello E., et al. Oxidative DNA damage drives carcinogenesis in MUTYH-associated-polyposis by specific mutations of mitochondrial and MAPK genes. Mod Pathol 2013, 26:1371-1381.
27. Bamford S., Dawson E., Forbes S., et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 2004, 91:355-358.
28. Forbes S.A., Tang G., Bindal N., et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 2010, 38:D652-D657.
29. Church J., Heald B., Burke C., et al. Understanding MYH-associated neoplasia. Dis Colon Rectum 2012, 55:359-362.
30. Buisine M.P., Cattan S., Wacrenier A., et al. Identification of a patient with atypical MUTYH-associated polyposis through detection of the KRAS c.34G>T mutation in liver metastasis. J Clin Oncol 2013, 31:e125-e127.
31. Borras E., Taggart M.W., Lynch P.M., et al. Establishing a diagnostic road map for MUTYH-associated polyposis. Clin Cancer Res 2014, 20:1061-1063.
32. Grover S., Kastrinos F., Steyerberg E.W., et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA 2012, 308:485-492.